Skip to main content

Market Overview

Adamas Pharmaceuticals (NASDAQ: ADMS)

5.13 +0.04 (0.79%)

Analyst Ratings

DateResearch FirmActionCurrentPT
6/07/21HC Wainwright & Co.MaintainsBuy10.0
12/17/19Cantor FitzgeraldReiteratesNeutral7.0
9/30/19B of A SecuritiesDowngradesUnderperform
9/09/19Cantor FitzgeraldInitiates Coverage OnNeutral8.0
3/05/19Cowen & Co.DowngradesMarket Perform15.0
11/13/18Leerink SwannInitiates Coverage OnOutperform20.0
10/05/18B of A SecuritiesDowngradesNeutral25.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter